Skip to main content

Late-Life Mood Disorders May Indicate Predisposition to Dementia

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 30, 2025.

via HealthDay

MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9 in Alzheimer's & Dementia.

Shin Kurose, from the National Institutes for Quantum Science and Technology in Japan, and colleagues examined the involvement of AD and non-AD tau pathologies in a study involving 52 participants with LLMDs and 47 age- and sex-matched healthy controls. Participants underwent tau and amyloid beta (Aβ) positron emission tomography (PET) imaging using 18F-florzolotau and 11C-Pittsburgh compound B. In addition, a clinicopathological correlation analysis was conducted in 208 autopsy cases, including neurodegenerative diseases.

The researchers found that compared with healthy controls, participants with LLMDs were more likely to be tau PET- and Aβ PET-positive. These results were supported by the postmortem results that showed higher likelihood of diverse tauopathies in patients with versus those without late-life mania or depression.

"Because most of the participants with LLMDs in our study had no or mild cognitive decline, these results support the evidence that neurodegenerative diseases, including Alzheimer and non-Alzheimer tau-related pathologies, can initially manifest as psychiatric symptoms," Kurose said in a statement.

Two authors hold patents on compounds related to this study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes

THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...

Suicide-Specific Therapy App Effectively Cuts Suicidal Behavior in High-Risk Inpatients

THURSDAY, Aug. 14, 2025 -- A mobile phone app designed to deliver suicide-specific therapy reduces suicidal behavior among high-risk psychiatric inpatients, according to a study...

Metformin Use Tied to Lower Risk for Dementia, Death in Adults With Overweight, Obesity

TUESDAY, Aug. 12, 2025 -- Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.